| Literature DB >> 33321805 |
Maria Gloria Mumolo1, Francesco Rettura1, Sara Melissari1, Francesco Costa1, Angelo Ricchiuti1, Linda Ceccarelli1, Nicola de Bortoli1, Santino Marchi1, Massimo Bellini1.
Abstract
The gluten-free diet (GFD) has gained increasing popularity in recent years, supported by marketing campaigns, media messages and social networks. Nevertheless, real knowledge of gluten and GF-related implications for health is still poor among the general population. The GFD has also been suggested for non-celiac gluten/wheat sensitivity (NCG/WS), a clinical entity characterized by intestinal and extraintestinal symptoms induced by gluten ingestion in the absence of celiac disease (CD) or wheat allergy (WA). NCG/WS should be regarded as an "umbrella term" including a variety of different conditions where gluten is likely not the only factor responsible for triggering symptoms. Other compounds aside from gluten may be involved in the pathogenesis of NCG/WS. These include fructans, which are part of fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAPs), amylase trypsin inhibitors (ATIs), wheat germ agglutinin (WGA) and glyphosate. The GFD might be an appropriate dietary approach for patients with self-reported gluten/wheat-dependent symptoms. A low-FODMAP diet (LFD) should be the first dietary option for patients referring symptoms more related to FODMAPs than gluten/wheat and the second-line treatment for those with self-reported gluten/wheat-related symptoms not responding to the GFD. A personalized approach, regular follow-up and the help of a skilled dietician are mandatory.Entities:
Keywords: celiac disease; gluten; gluten-free diet; irritable bowel syndrome; low FODMAP diet; non-celiac gluten/wheat sensitivity
Mesh:
Substances:
Year: 2020 PMID: 33321805 PMCID: PMC7762999 DOI: 10.3390/nu12123785
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717